Newborn screening: rationale for a comprehensive, fully integrated public health system
Newborn screening has existed for approximately four decades [1]. During that period of time, newborn screening has evolved conceptually from a laboratory test for a single disorder, phenylketonuria (PKU), to a multi-part public health system involving education, screening, diagnostic follow-up, t...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés |
| Publicado: |
Universidad de Belgrano - Documentos CEEGMD - Centro para el estudio de enfermedades genéticas, metabólicas y discapacidades. Facultad de Ciencias Exactas
2014
|
| Materias: | |
| Acceso en línea: | http://repositorio.ub.edu.ar/handle/123456789/2876 |
| Aporte de: |
| Sumario: | Newborn screening has existed for approximately four decades [1]. During that period of time, newborn screening has
evolved conceptually from a laboratory test for a single disorder, phenylketonuria (PKU), to a multi-part public health system
involving education, screening, diagnostic follow-up, treatment/management, and system evaluation [2–5]. At a time when
newborn screening is recognized as a model for predictive medicine [6,7], it also faces critical challenges that will determine its
future credibility and viability. In order to understand these challenges, it is helpful to review briefly the history of newborn
screening. |
|---|